{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:07:04Z","timestamp":1792782424043,"version":"4.5.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T00:00:00Z","timestamp":1790035200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T00:00:00Z","timestamp":1790035200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"the Shijiazhuang University Doctoral Research Start-up Fund Project","award":["22BS007"],"award-info":[{"award-number":["22BS007"]}],"id":[{"id":"https:\/\/ror.org\/028rmam09","id-type":"ROR","asserted-by":"crossref"}]},{"name":"the Shijiazhuang Science and Technology Plan Project","award":["231201123"],"award-info":[{"award-number":["231201123"]}]},{"name":"the Science Research Project of Hebei Education Department","award":["QN2024050"],"award-info":[{"award-number":["QN2024050"]}]},{"name":"the Natural Science Foundation of Hebei Province","award":["H2024423040"],"award-info":[{"award-number":["H2024423040"]}]},{"name":"the Hebei Traditional Chinese Medicine Administration Project","award":["2022088"],"award-info":[{"award-number":["2022088"]}]},{"name":"the Health Commission of Hebei Province project","award":["20221488"],"award-info":[{"award-number":["20221488"]}],"id":[{"id":"https:\/\/ror.org\/02g4yc525","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Nat"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s00114-026-02166-4","type":"journal-article","created":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T06:11:54Z","timestamp":1790057514000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Bellidifolin alleviates doxorubicin-induced hepatotoxicity: a study integrating network pharmacology, molecular docking, and experimental validation"],"prefix":"10.1007","volume":"113","author":[{"given":"Ying","family":"Cao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongrong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiping","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aiying","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutao","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangli","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,22]]},"reference":[{"key":"2166_CR1","doi-asserted-by":"publisher","first-page":"73","DOI":"10.46871\/eams.2020.10","volume":"3","author":"AT Akn","year":"2021","unstructured":"Akn AT, Kaymak E, Karabulut D, Doanyiit Z, Ceylan T, Toluk A, Zdamar S (2021) Comparison of the acute and cumulative dose administrations in doxorubicin-induced hepatotoxicity via evaluation of the histopathological changes and inflammation in rats. Exp Appl Med Sci 3:73\u201381. https:\/\/doi.org\/10.46871\/eams.2020.10","journal-title":"Exp Appl Med Sci"},{"key":"2166_CR2","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1186\/S12917-018-1688-5","volume":"14","author":"S Al-Nadaf","year":"2018","unstructured":"Al-Nadaf S, Rebhun RB, Curran KM, Venable RO, Skorupski KA, Willcox JL, Burton JH (2018) Retrospective analysis of doxorubicin and prednisone as first-line therapy for canine B-cell lymphoma. BMC Vet Res 14:356. https:\/\/doi.org\/10.1186\/S12917-018-1688-5","journal-title":"BMC Vet Res"},{"key":"2166_CR3","doi-asserted-by":"publisher","unstructured":"Aljobaily N, Viereckl MJ, Hydock DS, Aljobaily H, Wu TY, Busekrus R, Jones B, Alberson J, Han Y (2020) Creatine alleviates doxorubicin-induced liver damage by inhibiting liver fibrosis, inflammation, oxidative stress, and cellular senescence. Nutrients 13. https:\/\/doi.org\/10.3390\/nu13010041","DOI":"10.3390\/nu13010041"},{"key":"2166_CR4","doi-asserted-by":"publisher","first-page":"27203","DOI":"10.1038\/s41598-025-09675-8","volume":"15","author":"TG Alsahli","year":"2025","unstructured":"Alsahli TG, Alharbi KS, Alenezi SK, Alqahtani R, Afzal M, Sayyed N (2025) Aegeline improves doxorubicin-induced liver toxicity by modulating oxidative stress and Bax\/Bcl2\/caspase\/NF-\u03baB signaling. Sci Rep 15:27203. https:\/\/doi.org\/10.1038\/s41598-025-09675-8","journal-title":"Sci Rep"},{"key":"2166_CR5","doi-asserted-by":"publisher","first-page":"2794","DOI":"10.1007\/s11064-023-03943-7","volume":"48","author":"D An","year":"2023","unstructured":"An D, Xu W, Ge Y, Ge Y, Zhang L, Zhu Y, Zhang Z, Fan J, Gao R, Jiang L, Huang P, Wang J, Chen X (2023) Protection of oxygen glucose deprivation-induced human brain vascular pericyte injury: beneficial effects of bellidifolin in cellular pyroptosis. Neurochem Res 48:2794\u20132807. https:\/\/doi.org\/10.1007\/s11064-023-03943-7","journal-title":"Neurochem Res"},{"key":"2166_CR6","doi-asserted-by":"publisher","first-page":"2260","DOI":"10.1111\/liv.15326","volume":"42","author":"E Cervantes-Alvarez","year":"2022","unstructured":"Cervantes-Alvarez E, Limon-de la Rosa N, Vilatoba M, P\u00e9rez-Monter C, Hurtado-Gomez S, Martinez-Cabrera C, Argemi J, Alatorre-Arenas E, Yarza-Regalado S, Tejeda-Dominguez F, Lizardo-Thiebaud MJ, Mendez-Guerrero O, Gamboa-Dominguez A, Aguilar-Salinas CA, Huang CA, Kershenobich D, Bataller R, Torre A, Navarro-Alvarez N (2022) Galectin-3 is overexpressed in advanced cirrhosis and predicts post-liver transplant infectious complications. Liver Int 42:2260\u20132273. https:\/\/doi.org\/10.1111\/liv.15326","journal-title":"Liver Int"},{"key":"2166_CR7","doi-asserted-by":"publisher","first-page":"255","DOI":"10.36401\/JIPO-24-6","volume":"7","author":"S Chamseddine","year":"2024","unstructured":"Chamseddine S, Yavuz BG, Mohamed YI, Lee SS, Yao JC, Hu ZI, LaPelusa M, Xiao L, Sun R, Morris JS, Hatia RI, Hassan M, Duda DG, Diab M, Mohamed A, Nassar A, Amin HM, Kaseb AO (2024) Circulating Galectin-3: a prognostic biomarker in hepatocellular carcinoma. J Immunother Precis Oncol 7:255\u2013262. https:\/\/doi.org\/10.36401\/JIPO-24-6","journal-title":"J Immunother Precis Oncol"},{"key":"2166_CR8","doi-asserted-by":"publisher","first-page":"156751","DOI":"10.1016\/j.phymed.2025.156751","volume":"142","author":"SY Chang","year":"2025","unstructured":"Chang SY, Li YT, Zhu HY, He ZX, You Y, Liu YH (2025) Buyang Huanwu Decoction stabilizes atherosclerotic vulnerable plaques by regulating intestinal flora, TLR4-NF-\u03baB-NLRP3 inflammatory pathway and mitophagy. Phytomedicine 142:156751. https:\/\/doi.org\/10.1016\/j.phymed.2025.156751","journal-title":"Phytomedicine"},{"key":"2166_CR9","doi-asserted-by":"publisher","first-page":"153757","DOI":"10.1016\/j.tox.2024.153757","volume":"503","author":"M Chen","year":"2024","unstructured":"Chen M, Yi Y, Chen B, Zhang H, Dong M, Yuan L, Zhou H, Jiang H, Ma Z (2024) Metformin inhibits OCTN1- and OCTN2-mediated hepatic accumulation of doxorubicin and alleviates its hepatotoxicity in mice. Toxicology 503:153757. https:\/\/doi.org\/10.1016\/j.tox.2024.153757","journal-title":"Toxicology"},{"key":"2166_CR10","doi-asserted-by":"publisher","first-page":"74","DOI":"10.4103\/2141-9248.126619","volume":"4","author":"G Damodar","year":"2014","unstructured":"Damodar G, Smitha T, Gopinath S, Vijayakumar S, Rao Y (2014) An evaluation of hepatotoxicity in breast cancer patients receiving injection doxorubicin. Ann Med Health Sci Res 4:74\u201379. https:\/\/doi.org\/10.4103\/2141-9248.126619","journal-title":"Ann Med Health Sci Res"},{"key":"2166_CR11","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.ajg.2021.03.002","volume":"22","author":"S Del Turco","year":"2021","unstructured":"Del Turco S, De Simone P, Ghinolfi D, Gaggini M, Basta G (2021) Comparison between galectin-3 and YKL-40 levels for the assessment of liver fibrosis in cirrhotic patients. Arab J Gastroenterol 22:187\u2013192. https:\/\/doi.org\/10.1016\/j.ajg.2021.03.002","journal-title":"Arab J Gastroenterol"},{"key":"2166_CR12","doi-asserted-by":"publisher","first-page":"e70669","DOI":"10.1002\/jbt.70669","volume":"40","author":"FN Ekinci Akdemir","year":"2026","unstructured":"Ekinci Akdemir FN, G\u00fcler MC, Eraslan E, Tanyeli A, Yildirim S, Kandemir FM, K\u00fc\u00e7\u00fckler S (2026) The effects of galangin mitigating doxorubicin-induced hepatorenal injury. J Biochem Mol Toxic 40:e70669. https:\/\/doi.org\/10.1002\/jbt.70669","journal-title":"J Biochem Mol Toxic"},{"key":"2166_CR13","doi-asserted-by":"publisher","first-page":"e70465","DOI":"10.1002\/jbt.70465","volume":"39","author":"AA Elhemiely","year":"2025","unstructured":"Elhemiely AA, El-Fayoumi SH, Gadelmawla M, Mahran NA, Gad AM (2025) Hesperidin reduces hepatic injury induced by doxorubicin in rat model through its antioxidative and anti-inflammatory effects, focusing on SIRT-1\/NRF-2 pathways. J Biochem Mol Toxicol 39:e70465. https:\/\/doi.org\/10.1002\/jbt.70465","journal-title":"J Biochem Mol Toxicol"},{"key":"2166_CR14","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1007\/s11095-018-2456-8","volume":"35","author":"H He","year":"2018","unstructured":"He H, Liu C, Wu Y, Zhang X, Fan J, Cao Y (2018) A multiscale physiologically-based pharmacokinetic model for doxorubicin to explore its mechanisms of cytotoxicity and cardiotoxicity in human physiological contexts. Pharm Res 35:174. https:\/\/doi.org\/10.1007\/s11095-018-2456-8","journal-title":"Pharm Res"},{"key":"2166_CR15","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.molmed.2024.11.006","volume":"31","author":"Q Jiang","year":"2025","unstructured":"Jiang Q, Zhao Q, Li P (2025) Galectin-3 in metabolic disorders: mechanisms and therapeutic potential. Trends Mol Med 31:424\u2013437. https:\/\/doi.org\/10.1016\/j.molmed.2024.11.006","journal-title":"Trends Mol Med"},{"key":"2166_CR16","doi-asserted-by":"publisher","unstructured":"Kciuk M, Gieleci\u0144ska A, Mujwar S, Ko\u0142at D, Ka\u0142uzi\u0144ska-Ko\u0142at \u017b, Celik I, Kontek R (2023) Doxorubicin-an agent with multiple mechanisms of anticancer activity. Cells 12. https:\/\/doi.org\/10.3390\/cells12040659","DOI":"10.3390\/cells12040659"},{"key":"2166_CR17","doi-asserted-by":"publisher","first-page":"3393","DOI":"10.1007\/s00204-025-04075-3","volume":"99","author":"X Kuang","year":"2025","unstructured":"Kuang X, Naiki-Ito A, Kawamura H, Murakami A, Komura M, Kato H, Nagayasu Y, Takahashi S (2025) Hepatic stellate cell inhibition by angiotensin II receptor blocker mitigates liver injury and fibrosis via NF-\u03baB-galectin-3 suppression in a rat nonalcoholic steatohepatitis model. Arch Toxicol 99:3393\u20133412. https:\/\/doi.org\/10.1007\/s00204-025-04075-3","journal-title":"Arch Toxicol"},{"key":"2166_CR18","doi-asserted-by":"publisher","first-page":"9099","DOI":"10.1007\/s00210-024-03688-2","volume":"398","author":"S Lal-Shahsavar","year":"2025","unstructured":"Lal-Shahsavar S, Zolbanin NM, Jafari A, Ghasemnejad-Berenji M (2025) Metformin alleviates doxorubicin-induced hepatic damage by modulating oxidative stress: a molecular, biochemical, and histopathological approach in a rat model. Naunyn Schmiedebergs Arch Pharmacol 398:9099\u20139107. https:\/\/doi.org\/10.1007\/s00210-024-03688-2","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"2166_CR44","doi-asserted-by":"publisher","first-page":"1723791","DOI":"10.1155\/2020\/1723791","volume":"2020","author":"Y Li","year":"2020","unstructured":"Li Y, Luo Y, Li C, Feng C, Zhu Z, Ren W, Ma Y, Zhou X, Wang B, Jin X, Liu Y (2020) Bellidifolin inhibits proliferation of A549 cells by regulating STAT3\/COX-2 expression and protein activity. J Oncol 2020:1723791. https:\/\/doi.org\/10.1155\/2020\/1723791","journal-title":"J Oncol"},{"key":"2166_CR19","doi-asserted-by":"publisher","first-page":"335","DOI":"10.4196\/kjpp.2022.26.5.335","volume":"26","author":"HL Li","year":"2022","unstructured":"Li HL, Li T, Chen ZQ, Li L (2022a) Tanshinone IIA reduces pyroptosis in rats with coronary microembolization by inhibiting the TLR4\/MyD88\/NF-\u03baB\/NLRP3 pathway. Korean J Physiol Pharmacol 26:335\u2013345. https:\/\/doi.org\/10.4196\/kjpp.2022.26.5.335","journal-title":"Korean J Physiol Pharmacol"},{"key":"2166_CR20","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1016\/j.toxrep.2022.08.006","volume":"9","author":"S Li","year":"2022","unstructured":"Li S, Huang C, Li X, Meng X, Wen R, Zhang X, Zhang C, Li M (2022b) Bellidifolin from Gentianella acuta (Michx.) Hulten protects H9c2 cells from hydrogen peroxide-induced injury via the PI3K-Akt signal pathway. Toxicol Rep 9:1655\u20131665. https:\/\/doi.org\/10.1016\/j.toxrep.2022.08.006","journal-title":"Toxicol Rep"},{"key":"2166_CR21","doi-asserted-by":"publisher","first-page":"6140","DOI":"10.1038\/s41598-026-37061-5","volume":"16","author":"Z Li","year":"2026","unstructured":"Li Z, Xi R, Han X, Zhao P (2026) Research on the molecular mechanism of celastrol targeting CTNNB1\/STAT3 to inhibit uveal melanoma based on network pharmacology and multi-omics analysis. Sci Rep-Uk 16:6140. https:\/\/doi.org\/10.1038\/s41598-026-37061-5","journal-title":"Sci Rep-Uk"},{"key":"2166_CR22","doi-asserted-by":"publisher","first-page":"1151196","DOI":"10.3389\/fphar.2023.1151196","volume":"14","author":"JX Long","year":"2023","unstructured":"Long JX, Tian MZ, Chen XY, Yu HH, Ding H, Liu F, Du K (2023) The role of NLRP3 inflammasome-mediated pyroptosis in ischemic stroke and the intervention of traditional Chinese medicine. Front Pharmacol 14:1151196. https:\/\/doi.org\/10.3389\/fphar.2023.1151196","journal-title":"Front Pharmacol"},{"key":"2166_CR23","doi-asserted-by":"publisher","first-page":"177077","DOI":"10.1016\/j.ejphar.2024.177077","volume":"985","author":"AC MacKinnon","year":"2024","unstructured":"MacKinnon AC, Humphries DC, Herman K, Roper JA, Holyer I, Mabbitt J, Mills R, Nilsson UJ, Leffler H, Pedersen A, Schambye H, Zetterberg F, Slack RJ (2024) Effect of GB1107, a novel galectin-3 inhibitor on pro-fibrotic signalling in the liver. Eur J Pharmacol 985:177077. https:\/\/doi.org\/10.1016\/j.ejphar.2024.177077","journal-title":"Eur J Pharmacol"},{"key":"2166_CR24","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1080\/08923973.2025.2482863","volume":"47","author":"HM Mahmoud","year":"2025","unstructured":"Mahmoud HM, Hassanein E, Khalaf MM (2025) Vildagliptin attenuates doxorubicin-induced hepatotoxicity via activating Nrf2\/HO-1 and SIRT1 and suppressing NF-\u03baB signals in rats. Immunopharmacol Immunotoxicol 47:364\u2013374. https:\/\/doi.org\/10.1080\/08923973.2025.2482863","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"2166_CR25","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1007\/s00210-023-02429-1","volume":"396","author":"F Mahmoudi","year":"2023","unstructured":"Mahmoudi F, Arasteh O, Elyasi S (2023) Preventive and therapeutic use of herbal compounds against doxorubicin induced hepatotoxicity: a comprehensive review. Naunyn Schmiedebergs Arch Pharmacol 396:1595\u20131617. https:\/\/doi.org\/10.1007\/s00210-023-02429-1","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"2166_CR26","doi-asserted-by":"publisher","first-page":"e0298284","DOI":"10.1371\/journal.pone.0298284","volume":"19","author":"M Matsuo","year":"2024","unstructured":"Matsuo M, Kanbe A, Noguchi K, Niwa A, Imaizumi Y, Kuroda T, Ichihashi K, Okubo T, Mori K, Kanayama T, Tomita H, Hara A (2024) Time-course analysis of liver and serum galectin-3 in acute liver injury after alpha-galactosylceramide injection. PLoS ONE 19:e0298284. https:\/\/doi.org\/10.1371\/journal.pone.0298284","journal-title":"PLoS ONE"},{"key":"2166_CR27","doi-asserted-by":"publisher","first-page":"111965","DOI":"10.1016\/j.intimp.2024.111965","volume":"132","author":"O Memet","year":"2024","unstructured":"Memet O, Cao C, Hu H, Dun Y, Bao X, Liu F, Zhang L, Zhou J, Shen J (2024) Galectin-3 inhibition ameliorates alveolar epithelial cell pyroptosis in phosgene-induced acute lung injury. Int Immunopharmacol 132:111965. https:\/\/doi.org\/10.1016\/j.intimp.2024.111965","journal-title":"Int Immunopharmacol"},{"key":"2166_CR28","doi-asserted-by":"publisher","first-page":"117599","DOI":"10.1016\/j.lfs.2020.117599","volume":"250","author":"PL Prasanna","year":"2020","unstructured":"Prasanna PL, Renu K, Valsala Gopalakrishnan A (2020) New molecular and biochemical insights of doxorubicin-induced hepatotoxicity. Life Sci 250:117599. https:\/\/doi.org\/10.1016\/j.lfs.2020.117599","journal-title":"Life Sci"},{"key":"2166_CR29","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.lfs.2018.03.023","volume":"200","author":"A Pugazhendhi","year":"2018","unstructured":"Pugazhendhi A, Edison T, Velmurugan BK, Jacob JA, Karuppusamy I (2018) Toxicity of doxorubicin (Dox) to different experimental organ systems. Life Sci 200:26\u201330. https:\/\/doi.org\/10.1016\/j.lfs.2018.03.023","journal-title":"Life Sci"},{"key":"2166_CR30","doi-asserted-by":"publisher","first-page":"e70127","DOI":"10.1111\/cns.70127","volume":"30","author":"Q Qiu","year":"2024","unstructured":"Qiu Q, Li C, Zhao X, Yang M, Ding S, Liang H, Chen T (2024) Farnesylthiosalicylic acid through inhibition of Galectin-3 improves neuroinflammation in Alzheimer disease via multiple pathways. CNS Neurosci Ther 30:e70127. https:\/\/doi.org\/10.1111\/cns.70127","journal-title":"CNS Neurosci Ther"},{"key":"2166_CR31","doi-asserted-by":"publisher","first-page":"102111","DOI":"10.1016\/j.tice.2023.102111","volume":"82","author":"XX Shao","year":"2023","unstructured":"Shao XX, Xu Y, Xiao HY, Hu Y, Jiang Y (2023) Higenamine improves DSS-induced ulcerative colitis in mice through the Galectin-3\/TLR4\/NF-\u03baB pathway. Tissue Cell 82:102111. https:\/\/doi.org\/10.1016\/j.tice.2023.102111","journal-title":"Tissue Cell"},{"key":"2166_CR32","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s40360-025-00932-0","volume":"26","author":"A Soltani Hekmat","year":"2025","unstructured":"Soltani Hekmat A, Hekmat M, Ramezanipour S, Javanmardi K (2025) Protective effects of alamandine against doxorubicin-induced liver injury in rats. BMC Pharmacol Toxicol 26:95. https:\/\/doi.org\/10.1186\/s40360-025-00932-0","journal-title":"BMC Pharmacol Toxicol"},{"key":"2166_CR38","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.3389\/fphar.2019.01030","volume":"10","author":"S Song","year":"2019","unstructured":"Song S, Chu L, Liang H, Chen J, Liang J, Huang Z, Zhang B, Chen X (2019) Protective effects of Dioscin against doxorubicin-induced hepatotoxicity via regulation of Sirt1\/FOXO1\/NF-\u03bab signal. Front Pharmacol 10:1030. https:\/\/doi.org\/10.3389\/fphar.2019.01030","journal-title":"Front Pharmacol"},{"key":"2166_CR33","doi-asserted-by":"publisher","first-page":"239","DOI":"10.3390\/cimb48030239","volume":"48","author":"L Song","year":"2026","unstructured":"Song L, Meng J, Li H, Fu W, Hong K, Shen S, Zhang Z, Ding S, Li S, Zhang Z, Bei W, Huo H, Tan Y, Sui F, Liu L (2026) Triptonide suppresses AML via PI3K\/AKT signaling: a network pharmacology approach validated by molecular docking and experimental studies. Curr Issues Mol Biol 48:239. https:\/\/doi.org\/10.3390\/cimb48030239","journal-title":"Curr Issues Mol Biol"},{"key":"2166_CR34","doi-asserted-by":"publisher","first-page":"119527","DOI":"10.1016\/j.lfs.2021.119527","volume":"278","author":"S Sritharan","year":"2021","unstructured":"Sritharan S, Sivalingam N (2021) A comprehensive review on time-tested anticancer drug doxorubicin. Life Sci 278:119527. https:\/\/doi.org\/10.1016\/j.lfs.2021.119527","journal-title":"Life Sci"},{"key":"2166_CR35","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1159\/000534833","volume":"30","author":"W Sun","year":"2023","unstructured":"Sun W, Hao Y, Li C, Zhao Y, Yu H, Wang L (2023) Inhibition of Galectin-3 in a rat model of epilepsy and kainate-activated BV2 cells limits microglial activation through the NLRP3\/Pyroptosis pathway. Neuroimmunomodulation 30:325\u2013337. https:\/\/doi.org\/10.1159\/000534833","journal-title":"Neuroimmunomodulation"},{"key":"2166_CR36","doi-asserted-by":"publisher","first-page":"149560","DOI":"10.1016\/j.brainres.2025.149560","volume":"1855","author":"Y Sun","year":"2025","unstructured":"Sun Y, Gao SQ, Wang X, Li T, Han YL, Miao SH, Zhao R, Zheng XB, Qiu JY, Jin WX, Gao CC, Zhou ML (2025) Galectin-3 activates microglia and promotes neurological impairment via NLRP3\/pyroptosis pathway following traumatic brain injury. Brain Res 1855:149560. https:\/\/doi.org\/10.1016\/j.brainres.2025.149560","journal-title":"Brain Res"},{"key":"2166_CR37","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/s41577-019-0165-0","volume":"19","author":"KV Swanson","year":"2019","unstructured":"Swanson KV, Deng M, Ting JP (2019) The NLRP3 inflammasome: molecular activation and regulation to therapeutics. Nat Rev Immunol 19:477\u2013489. https:\/\/doi.org\/10.1038\/s41577-019-0165-0","journal-title":"Nat Rev Immunol"},{"key":"2166_CR39","doi-asserted-by":"publisher","first-page":"122826","DOI":"10.1016\/j.carbpol.2024.122826","volume":"348","author":"B Tang","year":"2025","unstructured":"Tang B, Jin C, Li M, Liu S, Zhang X, Li J, Ding K, Zang Y (2025) A novel pectin-like polysaccharide from crocus sativus targets Galectin-3 to inhibit hepatic stellate cells activation and liver fibrosis. Carbohydr Polym 348:122826. https:\/\/doi.org\/10.1016\/j.carbpol.2024.122826","journal-title":"Carbohydr Polym"},{"key":"2166_CR40","doi-asserted-by":"publisher","first-page":"115335","DOI":"10.1016\/j.fct.2025.115335","volume":"199","author":"N Wang","year":"2025","unstructured":"Wang N, Gao Z, Zhan H, Jing L, Meng F, Chen M (2025) Salidroside alleviates doxorubicin-induced hepatotoxicity via Sestrin2\/AMPK-mediated pyroptotic inhibition. Food Chem Toxicol 199:115335. https:\/\/doi.org\/10.1016\/j.fct.2025.115335","journal-title":"Food Chem Toxicol"},{"key":"2166_CR41","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1002\/tox.23755","volume":"38","author":"Y Xi","year":"2023","unstructured":"Xi Y, Chi Z, Tao X, Zhai X, Zhao Z, Ren J, Yang S, Dong D (2023) Naringin against doxorubicin-induced hepatotoxicity in mice through reducing oxidative stress, inflammation, and apoptosis via the up-regulation of SIRT1. Environ Toxicol 38:1153\u20131161. https:\/\/doi.org\/10.1002\/tox.23755","journal-title":"Environ Toxicol"},{"key":"2166_CR42","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1002\/kjm2.12890","volume":"40","author":"J Xia","year":"2024","unstructured":"Xia J, Wang Y, Qi BR (2024) In vitro and in vivo effects of Galectin-3 inhibitor TD139 on inflammation and ERK\/JNK\/p38 pathway in gestational diabetes mellitus. Kaohsiung J Med Sci 40:916\u2013925. https:\/\/doi.org\/10.1002\/kjm2.12890","journal-title":"Kaohsiung J Med Sci"},{"key":"2166_CR43","doi-asserted-by":"publisher","first-page":"451","DOI":"10.7555\/JBR.37.20230169","volume":"38","author":"J Xue","year":"2024","unstructured":"Xue J, Zhang L, Tao J, Xie X, Wang X, Wu L, Du S, Tan N, Jin Y, Ju J, Fan J, Wang J, Huan F, Gao R (2024) A novel bellidifolin intervention mitigates nonalcoholic fatty liver disease-like changes induced by bisphenol F. J Biomed Res 38:451\u2013463. https:\/\/doi.org\/10.7555\/JBR.37.20230169","journal-title":"J Biomed Res"},{"key":"2166_CR45","doi-asserted-by":"publisher","first-page":"644886","DOI":"10.3389\/fphar.2021.644886","volume":"12","author":"HX Yang","year":"2021","unstructured":"Yang HX, Sun JH, Yao TT, Li Y, Xu GR, Zhang C, Liu XC, Zhou WW, Song QH, Zhang Y, Li AY (2021) Bellidifolin ameliorates isoprenaline-induced myocardial fibrosis by regulating TGF-\u03b21\/Smads and p38 signaling and preventing NR4A1 cytoplasmic localization. Front Pharmacol 12:644886. https:\/\/doi.org\/10.3389\/fphar.2021.644886","journal-title":"Front Pharmacol"},{"key":"2166_CR46","doi-asserted-by":"publisher","first-page":"102818","DOI":"10.1016\/j.tice.2025.102818","volume":"95","author":"B Zhang","year":"2025","unstructured":"Zhang B, Chen L, Kang M, Ai L, Tao Y (2025) Gegen Qinlian Decoction improves Alzheimer\u2019s disease through TLR4\/NF-\u03baB\/NLRP3 pathway. Tissue Cell 95:102818. https:\/\/doi.org\/10.1016\/j.tice.2025.102818","journal-title":"Tissue Cell"},{"key":"2166_CR47","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/s41420-023-01563-2","volume":"9","author":"D Zhou","year":"2023","unstructured":"Zhou D, Liu W, Zhang J, Dong Y, Wu J, Zhang Y, Dai C, Zhang T, Yang G, Zhang Y, Li A (2023) Bellidifolin ameliorates isoprenaline-induced cardiac hypertrophy by the Nox4\/ROS signalling pathway through inhibiting BRD4. Cell Death Discov 9:279. https:\/\/doi.org\/10.1038\/s41420-023-01563-2","journal-title":"Cell Death Discov"},{"key":"2166_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.sleep.2022.09.018","volume":"101","author":"D Zong","year":"2023","unstructured":"Zong D, Liu X, Shen C, Liu T, Ouyang R (2023) Involvement of Galectin-3 in neurocognitive impairment in obstructive sleep apnea via regulating inflammation and oxidative stress through NLRP3. Sleep Med 101:1\u201310. https:\/\/doi.org\/10.1016\/j.sleep.2022.09.018","journal-title":"Sleep Med"}],"container-title":["The Science of Nature"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00114-026-02166-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00114-026-02166-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00114-026-02166-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T12:23:06Z","timestamp":1792585386000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00114-026-02166-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,22]]},"references-count":48,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["2166"],"URL":"https:\/\/doi.org\/10.1007\/s00114-026-02166-4","relation":{},"ISSN":["0028-1042","1432-1904"],"issn-type":[{"value":"0028-1042","type":"print"},{"value":"1432-1904","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,22]]},"assertion":[{"value":"18 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This research has been approved by the Animal Ethics Committee of Hebei University of Chinese Medicine (Ethics committee number: DWLL202401003).","order":1,"name":"Ethics","label":"Ethics statement","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"118"}}